ghk-cu inhibits 5-alpha reductase ✨ Peptide Spotlight: ✨ GHK-Cu is a powerful copper peptide known for its regenerative and anti-aging benefits. Naturally found in the body, this peptide plays an important role in skin repair GHK-Cu 50mg – NewBioRx

Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research

Use vendors with third-party COA (98% purity)

doi: 10.1016/j.colsurfb.2007.02.006

Most available information comes from clinical trial protocols that don't translate easily to real-world use

Both options are safe when used correctly

Add in voluntary initiatives like the Institutional Limited Partners Associations Diversity in Action program, and its clear: PE firms that dont take DEI seriously now will face tougher scrutiny later